Biocept Inc is a cancer diagnostics company that develops and commercializes proprietary circulating tumor cell, or CTC, and circulating tumor DNA, or ctDNA, tests utilizing a standard blood sample or liquid biopsy.
| Website: | www.biocept.com |
| Main Phone: | +1 858 320-8200 |
| Address: | 5810 Nancy Ridge Drive |
| State: | CA |
| City / Town: | San Diego |
| Country: | USA |
| Postal Code: | 92121 |
| Exchange: | NSC |
| Employees: | 53 |
| NAICS: | Medical Laborato |
| Last Price 1.22 | Change $ -0.03 | Change % -2.40 | Tick N/A |
| Bid 1.10 | Bid Size 3,000.00 | Ask 1.48 | Ask Size 3,000.00 |
| Open 1.22 | High 1.24 | Low 1.22 | Prev Close 1.25 |
| Last Trade | Volume 123,789 | 52 Wk Hi 3.39 | 52 Wk Low 0.74 |
| Market Cap 36.9 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 30,253,743.00 | EPS (TTM) -1.03 | PE Ratio N/A | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 3 | 13 |
| Number of Buys | 3 | 13 |
| Number of Sells | 0 | 0 |
| Net Activity | 175000 | 558999 |
| Last 10 Buys | Shares |
|---|---|
| David F. Hale | 1,000 |
| David F. Hale | 1,000 |
| Edward Neff | 1,000 |
| Bruce E. Gerhardt | 1,000 |
| Bruce E. Gerhardt | 1,000 |
| Edward Neff | 1,000 |
| Veena Singh | 1,000 |
| Veena Singh | 1,000 |
| Marsha A. Chandler | 1,000 |
| Marsha A. Chandler | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Jeffrey H. Berg | 1,000 |
| David Pitler | 1,000 |
| David Pitler | 1,000 |
| David Pitler | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 2.5 | 2.5 | 2.5 | 2.5 |
| Low Target Price Estimate | 0.8 | 0.8 | 1.2 | 0.8 |
| Mean Target Price Estimate | 1.5 | 1.5 | 1.82 | 1.5 |
| Standard Deviation | 0.89 | 0.89 | 0.65 | 0.89 |
| Date of Most Recent Estimate | 08/03/16 | 08/03/16 | 06/06/16 | 08/03/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| S-1 | General form for registration of securities under the Securities Act of 1933 | 30 | 2016-08-12 |
| PRE 14A | Preliminary proxy statement providing notification matters to be brought to a vote | 31 | 2016-08-11 |
| S-8 | Securities offered to employees under employee benefit plans | 9 | 2016-08-05 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 40 | 2016-08-05 |
| 8-K | Report of unscheduled material events or corporate changes. | 38 | 2016-08-03 |
| 8-K | Report of unscheduled material events or corporate changes. | 8 | 2016-08-02 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-01 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-08-01 |
| 3 | Initial statement of beneficial ownership of securities | 1 | 2016-07-27 |
| 8-K | Report of unscheduled material events or corporate changes. | 63 | 2016-07-27 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 |
| Moderate Buy | 0 | 1 | 1 | 1 |
| Hold | 1 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.67 | 1.33 | 1.33 | 1.5 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
